Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Alkem Laboratories
Alkem Laboratories
Activities:
Manufacturing
Trending Articles
Ardena acquires Catalent's US oral dose manufacturing facility, adding further bioanalytical services
The CRO/CDMO will now integrate its advanced late-stage and small-scale commercial oral drug product manufacturing services with an extended list of bioanalytical services,...
Jabil acquires CDMO Pharmaceutics International
Pii's aseptic filling, lyophilisation and oral solid dose manufacturing capabilities will significantly bolster Jabil's pharmaceutical solutions offering
Guardtech encourage new clients to book ‘game-changing’ visit to their Cleancube Showroom
Suffolk-based firm have thrown open the doors of their award-winning shipping container solution to show Life Sciences firms what the fuss is all about
How is generative AI driving value in the life sciences sector?
Generative AI has the potential to expedite clinical discovery and to streamline timely processes
Eleva partners with 3PBIOVAN to boost the GMP manufacturing capacity of its pipeline programmes
The collaboration will almost triple Eleva's GMP biologics production capacity, allowing the company to further advance its dry AMD and C3G-focused clinical pipeline
Upcoming event
Pharma Packaging and Labelling Forum
5–6 March 2025 | Conference | San Diego, US
See all
Related Content
Manufacturing
Alkem subsidiary opens continuous biologics manufacturing facility
Indian CDMO Enzene Biosciences, built the new facility in half the time it takes for a conventional biologics manufacturing plant
Manufacturing
Alkem API plant in Gujarat gains EIR approval from US FDA
Indian firm started strengthening its US presence in 2010
Pharmaceutical
Indian manufacturers set to cash in on US generics market
Indian pharma companies are well positioned to generate strong revenues from the US generics market
Regulatory
News in Brief
Regulatory
India outpaces global companies launches
Subscribe now